Korean Drug Co Ltd (XKRX:014570) Share Price

Company Profile

Business description
Korean Drug Co Ltd is engaged in the business of manufacture and sale of pharmaceuticals. Its products include comprehensive cold remedies, hematopoietic nutrients, central nervous system agents, digestive system agents, dermatological agents, vitamins/nutritional supplements, antibiotics, antibacterials, antipyretics, analgesics, and anti-inflammatory agents. The group manufacture and sell over-the-counter medications, including Haben, Korea's cold remedy, as well as prescription drugs for various conditions, including central nervous system (CNS) diseases such as dementia, epilepsy, stroke, and Parkinson's disease.
Contact
69-10 Wonjeok-ro
Sindun-myeon
Gyeonggi-do
Icheon-si
KOR
T: +82 316347100
https://www.nicepharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
245

Recommended

Qantas’ budget brand performing well, with segment earnings up 55%.

Angus Hewitt, CFA | 31 August 2025

A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.

Brian Colello, CPA | 28 August 2025

A round up of notable stories and reactions as ASX reporting season rolls on.

Joseph Taylor | 28 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,168.00	7.10	-0.08%
CAC 40	7,654.25	53.65	-0.70%
DAX 40	23,487.33	550.00	-2.29%
Dow JONES (US)	45,295.81	249.07	-0.55%
FTSE 100	9,116.69	79.65	-0.87%
HKSE	25,496.55	120.87	-0.47%
NASDAQ	21,279.63	175.92	-0.82%
Nikkei 225	42,310.49	121.70	0.29%
NZX 50 Index	13,149.22	16.06	0.12%
S&P 500	6,415.54	44.72	-0.69%
S&P/ASX 200	8,900.60	1.50	-0.02%
SSE Composite Index	3,858.13	17.40	-0.45%